Median Technologies to Attend the 2019 European Congress of Radiology (ECR) from February 27 to March 3, 2019 in Vienna, Austria

  • Median Technologies Booth #AI-5, Expo X1, Artificial Intelligence
    Exhibition
  • Pitch on iBiopsy® scheduled for Feb. 28 at 1:40 pm CET, AI
    Theater
  • Scientific presentation on image management in oncology trials (iCRO
    activities) scheduled for March 1st, from 10:30 to 12:00 am
    CET (SS 1016)

SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News:

Median Technologies (Paris:ALMDT), The Imaging Phenomics Company®, will
be participating in the 2019 European Congress of Radiology (ECR), which
will take place from February 27th to March 3rd in
Vienna, Austria (exhibition dates: Feb 28-March 3).

Median will showcase its imaging phenomics platform iBiopsy® at Booth
#AI-5, Expo X1 located in the Artificial Intelligence Exhibition Hall.

On Feb 28 at 1:40 pm (CET), at the AI Theater (Expo X1), the company
will present and give a glimpse of iBiopsy® and how imaging phenomics
advance precision medicine and drug development.

In parallel, within the frame of its iCRO activities for image
management in oncology trials, Median Technologies will be presenting
results of a study co-authored with Sanofi (France), the University of
Pennsylvania (US), The Yonsei University of Medicine (South Korea), The
National Koranyi Institute (Hungary) and the Centre Antoine Lacassagne
(France). The study analyzes the reliability of radiological evaluations
in a RECIST 1.1 phase II clinical trial. The oral presentation “RECIST
1.1 evaluations in a phase II clinical trial: does reader expertise
represent a risk factor for measure reliability?”
will be held on
March 1st, from 10:30 to 12:00 am CET during the scientific
session SS 1016, Lung cancer: Screening and Beyond (Room M 3 – 1st
Level (M Building)).

The European Congress of Radiology organized by the European Society of
Radiology (ESR) is the European premier event in radiology and the
second largest in the world. It conveys more than 20,000 attendees with
a split of more than 10,000 professional delegates (radiologists,
technologists etc.), and ~8,000 industry participants (imaging
modalities, PACS etc.). Radiology professionals from Europe and beyond
attend to gather knowledge through educational courses, see the latest
innovations presented by technical exhibitors, discover groundbreaking
research from scientific paper presentations. More about the ECR: https://www.myesr.org/congress/about-ecr

About Median Technologies: Median Technologies provides
innovative imaging solutions and services to advance healthcare for
everyone. We leverage the power of Imaging Phenomics to provide insights
into novel therapies and treatment strategies. Our unique solutions for
medical image analysis and management in oncology trials and iBiopsy®
for imaging phenotyping, together with our global team of experts, are
advancing the development of new drugs and diagnostic tools to monitor
disease and assess response to therapy. Median Technologies supports
biopharmaceutical sponsors and healthcare professionals around the world
to quickly and precisely bring new treatments to patients in need. This
is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary
in Boston and another one in Shanghai, Median has received the label
“Innovative company” by the BPI and is listed on Euronext Growth market
(ISIN: FR0011049824, ticker: ALMDT). For more information: www.mediantechnologies.com

Contacts

Median Technologies
Emmanuelle Leygues
Senior Director,
Corporate Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Press
– ALIZE RP

Caroline Carmagnol / Aurore Gangloff
+ 33 1 44
54 36 66
median@alizerp.com

Investors
– ACTIFIN

Ghislaine Gasparetto
+33 1 56 88 11 11
ggasparetto@actifin.fr

error: Content is protected !!